Synapse

← JHEP Reports

Papers in JHEP Reports

Page 12 · newest first

  1. Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseasesJHEP Reports · 2024
  2. YAP mediates HIV-related liver fibrosisJHEP Reports · 2024
  3. Association of physical activity, including amount and maintenance, with the risk of HCC among patients with type 2 diabetesJHEP Reports · 2024
  4. Liver fibrosis screening increases alcohol abstinenceJHEP Reports · 2024
  5. Surrogate markers of bile duct disease progression in primary sclerosing cholangitis – A prospective study with repeated ERCP examinationsJHEP Reports · 2024
  6. Tumor organoids for primary liver cancers: A systematic review of current applications in diagnostics, disease modeling, and drug screeningJHEP Reports · 2024
  7. MASLD-related HCC: Multicenter study comparing patients with and without cirrhosisJHEP Reports · 2024
  8. Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progressionJHEP Reports · 2024
  9. Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cmJHEP Reports · 2024
  10. Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorderJHEP Reports · 2024
  11. External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohortJHEP Reports · 2024
  12. Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: an Italian liver transplant registry study.JHEP Reports · 2024
  13. A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASHJHEP Reports · 2024
  14. Response to: “Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCC”JHEP Reports · 2024
  15. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapyJHEP Reports · 2024
  16. Implementing a new HCV model of care for people who use drugsJHEP Reports · 2024
  17. Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretionJHEP Reports · 2024
  18. Hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated steatotic liver diseaseJHEP Reports · 2024
  19. CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1JHEP Reports · 2024
  20. Immunotherapy for hepatocellular carcinomaJHEP Reports · 2024
  21. Acute liver failure: A practical updateJHEP Reports · 2024
  22. Dietary pattern modifies the risk of MASLD through metabolomic signatureJHEP Reports · 2024
  23. HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBxJHEP Reports · 2024
  24. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort studyJHEP Reports · 2024
  25. Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoidsJHEP Reports · 2024
  26. Reply to: Correspondence on “Cardiomyopathy in cirrhosis: From pathophysiology to clinical care”JHEP Reports · 2024
  27. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE ScoreJHEP Reports · 2024
  28. AI-derived body composition parameters as prognostic factors in patients with HCC undergoing TACE in a multicenter studyJHEP Reports · 2024
  29. Good long-term outcomes of primary sclerosing cholangitis in childhoodJHEP Reports · 2024
  30. A molecular standard for circulating HBV RNA detection and quantification assays in chronic hepatitis B patientsJHEP Reports · 2024
  31. Successful hepatitis B and C screening in the health check-up in the German primary care settingJHEP Reports · 2024
  32. Cirrhotic cardiomyopathy and beyond: Underscoring the interaction between the liver and the heartJHEP Reports · 2024
  33. CD40 stimulation activates CD8+ T cells and controls HBV in CD4-depleted miceJHEP Reports · 2024
  34. Anticoagulation is not associated with an increased risk of variceal bleeding under systemic therapy for advanced HCCJHEP Reports · 2024
  35. Metabolomics biomarkers of hepatocellular carcinoma in a prospective cohort of patients with cirrhosisJHEP Reports · 2024
  36. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesisJHEP Reports · 2024
  37. Plasma cathepsin D as an early indicator of alcohol-related liver diseaseJHEP Reports · 2024
  38. Direct oral anticoagulants in cirrhosis: Rationale and current evidenceJHEP Reports · 2024
  39. Non-ceruloplasmin copper and urinary copper in clinically stable Wilson Disease: Alignment with recommended targetsJHEP Reports · 2024
  40. Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysisJHEP Reports · 2024
  41. Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre studyJHEP Reports · 2024
  42. The potential of volatile organic compounds to diagnose primary sclerosing cholangitisJHEP Reports · 2024
  43. Lifestyle and genetic risk of chronic liver disease in metabolically healthy and unhealthy individuals from the general populationJHEP Reports · 2024
  44. Bile acids attenuate hepatic inflammation during ischemia/reperfusion injuryJHEP Reports · 2024
  45. Dual-tracer PET/CT in the management of hepatocellular carcinomaJHEP Reports · 2024
  46. Drug-induced liver injury in children: A nationwide cohort study from ChinaJHEP Reports · 2024
  47. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR studyJHEP Reports · 2024
  48. Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeJHEP Reports · 2024
  49. CDK4/6 inhibitors-induced liver injury: Clinical phenotypes and role of the corticosteroid treatmentJHEP Reports · 2024
  50. Applications of single-cell multi-omics in liver cancerJHEP Reports · 2024